Preclinical News and Research

RSS
Soybean compounds can increase effectiveness of radiation treatment for lung cancer

Soybean compounds can increase effectiveness of radiation treatment for lung cancer

arGEN-X to advance SIMPLE Antibody platform for treatment of autoimmune disorders

arGEN-X to advance SIMPLE Antibody platform for treatment of autoimmune disorders

FIND, NUS collaborate to identify novel biomarkers for TB diagnosis

FIND, NUS collaborate to identify novel biomarkers for TB diagnosis

Positive results from Hatchtech's DeOvo Phase 2b trial on head lice

Positive results from Hatchtech's DeOvo Phase 2b trial on head lice

FUJIFILM to acquire SonoSite

FUJIFILM to acquire SonoSite

JHN to initiate new Phase I immunotherapy trial in glioblastoma

JHN to initiate new Phase I immunotherapy trial in glioblastoma

Isis announces addition of three new drug development candidates

Isis announces addition of three new drug development candidates

Ganitumab shows promise in early-phase trials for metastatic pancreatic cancer

Ganitumab shows promise in early-phase trials for metastatic pancreatic cancer

NYUCI experts present latest research findings about hematologic cancers at 53rd ASH meeting

NYUCI experts present latest research findings about hematologic cancers at 53rd ASH meeting

ISIS-FXIRx reduces Factor XI activity without bleeding in healthy volunteers

ISIS-FXIRx reduces Factor XI activity without bleeding in healthy volunteers

Synta's ganetespib shows potent in vitro and in vivo activity against multiple breast cancer types

Synta's ganetespib shows potent in vitro and in vivo activity against multiple breast cancer types

Plexxikon announces scientific findings from PLX3397 preclinical studies on AML

Plexxikon announces scientific findings from PLX3397 preclinical studies on AML

BioInvent announces new BI-505 preclinical data on multiple myeloma

BioInvent announces new BI-505 preclinical data on multiple myeloma

Syndax announces data from entinostat phase 2 study on HL

Syndax announces data from entinostat phase 2 study on HL

New cost-effective liquid solution can help fight antibiotic-resistant bacteria

New cost-effective liquid solution can help fight antibiotic-resistant bacteria

New cancer research findings presented at 53rd ASH annual meeting

New cancer research findings presented at 53rd ASH annual meeting

Positive data from Aeterna Zentaris AEZS-131 preclinical study on TNBC

Positive data from Aeterna Zentaris AEZS-131 preclinical study on TNBC

Positive results from Synta's Ganetespib Phase 2 trial on HER2-positive and triple negative mBC

Positive results from Synta's Ganetespib Phase 2 trial on HER2-positive and triple negative mBC

Galectin Therapeutics to initiate GM-CT-01 Phase 1/2 combination study in advanced MM

Galectin Therapeutics to initiate GM-CT-01 Phase 1/2 combination study in advanced MM

ChemoCentryx commences CCX140 Phase II trial in diabetic nephropathy

ChemoCentryx commences CCX140 Phase II trial in diabetic nephropathy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.